Lung Function Parameters in Patients with Dilated Cardiomyopathy Complicated by Pulmonary Hypertension
https://doi.org/10.20996/1819-6446-2016-12-5-542-546
Abstract
Aim. To study clinical and morphofunctional indicators of respiratory function in patients with dilated cardiomyopathy (DCM) with and without pulmonary hypertension (PH).
Material and methods. 91 patients with idiopathic DCM (34 women and 57 men; mean age of 46.4±13.7 years) were included into the study. 25 (27.4%) patients had right ventricular DCM (RV DCM). 6-minute walking test (6MWT), the standard 12-lead ECG, spirography, echocardiography were performed in all patients. PH occurred in 48 of DCM patients (Group I) and 43 DCM patients had no PH (Group II). A number of patients with RV DCM in Groups I and II was 11 (23%) and 14 (32.5%), respectively.
Results. Pulmonary artery systolic pressure (PASP) in group I was 48.1±10.7 mmHg (in 71% of the patients – degree 1 of PH, and in 29% - degree 2). A significant decrease in the majority of speed indicators of respiratory functions was found in Group I. The inverse relationship between PASP and Tiffno index (p=0.03) and a positive correlation between forced vital capacity (53.17±9.21%) and 6MWT distance (206.7±80.3 m; p=0.017) were found in patients of Group I.
Conclusion. PH syndrome often aggravates the DCM course. Forced expiratory volume in the first second, Tiffno index, and some speed indicators show disorders of respiratory function in DCM patients.
About the Authors
T. A. Abdullaev
Republican Specialized Center of Cardiology. Osie ul. 4, Tashkent, 100052 Uzbekistan
Russian Federation
Russian Federation
MD, PhD, Professor, Head of Laboratory of Heart Failure and Non-coronary Myocardial Diseases, Republican Specialized Center of Cardiology
Ya. R. Ahmatov
Republican Specialized Center of Cardiology. Osie ul. 4, Tashkent, 100052 Uzbekistan
Russian Federation
Russian Federation
MD, Junior Researcher, Laboratory of Heart Failure and Non-coronary Myocardial Diseases, Republican Specialized Center of Cardiology
B. U. Mardanov
State Research Centre for Preventive Medicine. Petroverigsky per. 10, Moscow, 101990 Russia
Russian Federation
Russian Federation
MD, PhD, Senior Researcher, State Research Center for Preventive Medicine
R. Sh. Bekbulatova
Republican Specialized Center of Cardiology. Osie ul. 4, Tashkent, 100052 Uzbekistan
Russian Federation
Russian Federation
MD, PhD, Senior Researcher, Laboratory of Heart Failure and Non-coronary Myocardial Diseases, Republican Specialized Center of Cardiology
References
1. Barry J.M. The 2006 American Heart Association Classification of Cardiomyopathies Is the Gold Standard. Circulation 2008;1:72-6.
2. Baksheev VI, Kolomoets NM, Tursunov GF. Clinical value of echocardiography techniques right heart. Klinicheskaya Meditsina 2006; 10: 16-23. In Russian (Бакшеев В.И., Коломоец Н.М., Турсунова Г.Ф. Клиническое значение методик эхокардиографического исследования правых отделов сердца. Клиническая Медицина 2006; 10: 16-23)
3. Gulati A., Ismail T.F., Jabbour A. The Prevalence and Prognostic Significance of Right Ventricular Systolic Dysfunction in Nonischemic Dilated Cardiomyopathy. Circulation 2013;128:1623-33.
4. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Organization International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996;93: 841-2.
5. Abdullayev TA, Ahmatov YR, Bekbulatova RSh, et al. Clinical and hemodynamic manifestations of right ventricular dilated cardiomyopathy. Serdechnaya Nedostatochnost' 2012; 4: 228-32. In Russian (Абдуллаев Т.А., Ахматов Я.Р., Бекбулатова Р.Ш. и др. Клинико-гемодинамические проявления правожелудочковой дилатационной кардиомиопатии. Сердечная Недостаточность 2012; 4: 228-32).
6. Mareev VY. Pharmacoeconomic evaluation of the use of ACE inhibitors in the treatment of ambulatory patients with heart failure (shapes). Serdechnaya Nedostatochnost' 2002; 3 (1): 38-9. In Russian (Мареев В. Ю. Фармако экономическая оценка использования иАПФ в амбулаторном лечении больных с сердечной недостаточностью (ФАСОН). Сердечная Недостаточность 2002; 3(1):38-9).
7. Mareev VY, Ageev FT, Arutyunov GP et al. National guidelines for diagnosis and treatment of chronic heart failure (fourth revision). Serdechnaya Nedostatochnost' 2013; 14 (7): 4-37. In Russian (Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П. и др. Национальные рекомендации по диагностике и лечению хронической сердечной недостаточности (четвертый пересмотр). Сердечная Недостаточность 2013; 14(7): 4-37).
8. Dixon DL, Griggs KM, De Pasquale CG, et al. Pulmonary effects of chronic elevation in microvascular pressure differ between hypertension and myocardial infarct induced heart failure. Heart Lung Circ 2015;24(2):158-64.
9. Breitling S, Ravindran K, Goldenberg NM, Kuebler WM. The pathophysiology of pulmonary hypertension in left heart disease. Am J Physiol Lung Cell Mol Physiol 2015;309(9):924-41.
10. Ramu B, Thenappan T. Evolving Concepts of Pulmonary Hypertension Secondary to Left Heart Disease. Curr Heart Fail Rep 2016 Feb 17. Epub ahead of print.
11. Shmelev EI. Chronic obstructive pulmonary disease and related conditions. Pulmonologiia 2007; 2: 5-9. In Russian (Шмелев Е.И. Хроническая обструктивная болезнь легких и сопутствующие заболевании. Пульмонология 2007;2:5-9).
12. Bazdyrev ED, Bairakov YuV, Polikutina OM, et al. The relationship of the respiratory function of the lungs and structural-functional state of the myocardium in patients with type 2 diabetes and coronary heart disease. Kardiologiia 2015; 1: 24-32. In Russian (Баздырев Е.Д., Байракова Ю.В., Поликутина О.М. и др. Взаимосвязь респираторной функции легких и структурно-функционального состояния миокарда у пациентов с сахарным диабетом 2-го типа и ишемической болезнью сердца. Кардиология 2015;1:24-32).
13. Murphy RM, Shah RV, Malhotra R, et al. Exercise Oscillatory Ventilation in Systolic Heart Failure: An Indicator of Impaired Hemodynamic Response to Exercise. Circulation 2011; 124(13): 1442-51.
Review
For citations:
Abdullaev T.A., Ahmatov Ya.R., Mardanov B.U., Bekbulatova R.Sh. Lung Function Parameters in Patients with Dilated Cardiomyopathy Complicated by Pulmonary Hypertension. Rational Pharmacotherapy in Cardiology. 2016;12(5):542-546. (In Russ.) https://doi.org/10.20996/1819-6446-2016-12-5-542-546
Views:
799
Email this article 